Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons

scientific article published in June 2001

Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1013789113
P356DOI10.1038/SJ.GT.3301469
P698PubMed publication ID11423934
P5875ResearchGate publication ID11916474

P2093author name stringWeibel M
Büeler H
Paterna JC
Furler S
P2860cites workThe cleavage activities of aphthovirus and cardiovirus 2A proteinsQ73016795
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsyQ73479417
Production of interleukin-12 as a self-processing 2A polypeptideQ77357481
???Q64821040
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinQ22251280
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropismQ24515072
Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous systemQ28141743
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disordersQ29614754
Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiationQ29615969
Internal ribosome entry site biology and its use in expression vectors.Q33744842
Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibersQ33782809
Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transferQ33802811
Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.Q33855715
Insertional mutagenesis of AAV2 capsid and the production of recombinant virusQ33883772
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.Q35057135
Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.Q35111738
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vectorQ35872651
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retinaQ36439639
Proteolytic processing of picornaviral polyproteinQ38004542
Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element.Q39580820
Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins.Q39719268
Expression of a foreign protein by influenza A virus.Q40038220
IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vectorQ40863150
The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell culturesQ40992568
Internal ribosomal entry site-containing retroviral vectors with green fluorescent protein and drug resistance markersQ41034868
Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteinsQ41044142
Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic retroviral vectorQ41057898
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainQ42280576
Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.Q42609041
Tricistronic and tetracistronic retroviral vectors for gene transferQ42796226
Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapyQ42812515
Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancerQ42824650
Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequenceQ43729049
Engineering cowpea mosaic virus RNA-2 into a vector to express heterologous proteins in plantsQ43817184
Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectorsQ43822089
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectorsQ45299117
Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.Q45745995
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldQ45747699
Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promotersQ45764253
Recombinant adeno-associated virus for muscle directed gene therapyQ45764433
Quantitative analysis of the packaging capacity of recombinant adeno-associated virusQ45766162
Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vectorQ45769447
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vectorQ45855552
Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectorsQ45867424
Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brainQ45869654
Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa.Q45888779
Self-processing 2A-polyproteins--a system for co-ordinate expression of multiple proteins in transgenic plants.Q53933906
Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient miceQ64381642
Proteolytic processing of the cardioviral P2 region: primary 2A/2B cleavage in clone-derived precursorsQ67503391
P433issue11
P921main subjectsubstantia nigraQ753278
vector-borne diseaseQ2083837
mouth diseaseQ2508462
P304page(s)864-873
P577publication date2001-06-01
P1433published inGene TherapyQ15763095
P1476titleRecombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons
P478volume8

Reverse relations

cites work (P2860)
Q39578448A bidirectional promoter architecture enhances lentiviral transgenesis in embryonic and extraembryonic stem cells
Q40318156A novel bicistronic expression system composed of the intraflagellar transport protein gene ift25 and FMDV 2A sequence directs robust nuclear gene expression in Chlamydomonas reinhardtii
Q40011728Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct
Q38011650Challenges in T cell receptor gene therapy.
Q34117035Comparison of IRES and F2A-based locus-specific multicistronic expression in stable mouse lines.
Q40477022Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters.
Q34244585Coordinate lentiviral expression of Cre recombinase and RFP/EGFP mediated by FMDV 2A and analysis of Cre activity
Q54125189Design of a Novel Gene Therapy Construct to Achieve Sustained Brain-Derived Neurotrophic Factor Signaling in Neurons.
Q36150485Development of 2A peptide-based strategies in the design of multicistronic vectors
Q24683066Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1
Q42088656Dual transgene expression by foamy virus vectors carrying an endogenous bidirectional promoter
Q35219552Dual transgene expression in murine cerebellar Purkinje neurons by viral transduction in vivo
Q42375722Evaluating the efficiency of CHEF and CMV promoter with IRES and Furin/2A linker sequences for monoclonal antibody expression in CHO cells
Q47965594Expression of Cholesterol Hydroxylase/Lyase System Proteins in Yeast S. cerevisiae Cells as a Self-Processing Polyprotein
Q51735696Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC Currents.
Q39827307Faithful expression of multiple proteins via 2A-peptide self-processing: a versatile and reliable method for manipulating brain circuits.
Q30537577Genetic dissection of an amygdala microcircuit that gates conditioned fear
Q42448457Herpes simplex virus type 1/adeno-associated virus hybrid vectors
Q45383286Immunogenicity and protective efficacy of Semliki forest virus replicon-based DNA vaccines encoding goatpox virus structural proteins
Q38812436Improved methods of AAV-mediated gene targeting for human cell lines using ribosome-skipping 2A peptide
Q37323354Live Attenuated Vaccine Based on Duck Enteritis Virus against Duck Hepatitis A Virus Types 1 and 3.
Q41614860MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectors.
Q42141797Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI
Q34966685Optimisation of the foot-and-mouth disease virus 2A co-expression system for biomedical applications.
Q44165281Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
Q35970584Overexpression of the Fibroblast Growth Factor Receptor 1 (FGFR1) in a Model of Spinal Cord Injury in Rats.
Q64941735Oxytocin-dependent reopening of a social reward learning critical period with MDMA.
Q38441659Production and characterization of soluble human TNFRI-Fc and human HO-1(HMOX1) transgenic pigs by using the F2A peptide
Q34987192Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain
Q96768562Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff Mice
Q41820621Protein coexpression using FMDV 2A: effect of "linker" residues.
Q34987182Recombinant adeno-associated virus vector design and gene expression in the mammalian brain
Q37305521Reporting neural activity with genetically encoded calcium indicators
Q40091495Structures and Corresponding Functions of Five Types of Picornaviral 2A Proteins
Q39975879Sustained analgesic peptide secretion and cell labeling using a novel genetic modification
Q39996419Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states
Q89548826The first full genome characterization of an Iranian foot and mouth disease virus
Q30653057The knottin-like Blufensin family regulates genes involved in nuclear import and the secretory pathway in barley-powdery mildew interactions
Q38841457The use of a viral 2A sequence for the simultaneous over-expression of both the vgf gene and enhanced green fluorescent protein (eGFP) in vitro and in vivo.
Q38438132The use of an adeno-associated viral vector for efficient bicistronic expression of two genes in the central nervous system
Q33908524Use of the 2A peptide for generation of multi-transgenic pigs through a single round of nuclear transfer.
Q33369539Use of the viral 2A peptide for bicistronic expression in transgenic mice
Q34285870Versatile somatic gene transfer for modeling neurodegenerative diseases

Search more.